Pemetrexed versus erlotinib in pretreated patients with advanced non–small cell lung cancer: A Hellenic Oncology Research Group (HORG) randomized phase 3 study
暂无分享,去创建一个
D. Mavroudis | V. Georgoulias | G. Samonis | A. Voutsina | S. Agelaki | J. Souglakos | A. Kotsakis | L. Vamvakas | A. Rapti | P. Papakotoulas | A. Karampeazis | M. Agelidou | N. Kentepozidis | S. Giassas | Charalambos Christofillakis